Back to Agenda
S10 : ”Smart” MIDD in the ICH-M15 Era: An Industry-Government Paradigm Shift in Drug Development - Clinical Pharmacology -
Session Chair(s)
Naoto Uemura, MD, PhD
Professor and Head of Clinical Pharmacology and General Clinical Research Center, Oita University Faculty of Medicine, Japan
Speaker(s)
Shuya Yoshida
Reviewer, Office of New Drug I, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Hanaka Mimura
PKPD & CP Senior Principal Scientist, Eli Lilly Japan K.K., Japan
Mayumi Hasegawa
Drug Development Solutions, Certara Inc., Japan
Yoshiyuki Tsuda
Research and Development, Clinical Pharmacology, Bayer Yakuhin, Ltd., Japan
Atsunori Kaibara, PhD
Principal Scientist, PKPD & PMx,Medicines Development Unit Japan, Eli Lilly Japan K.K., Japan
Have an account?